U.S. pharma giant copyright scrapped two experimental weight loss drugs very last year—a once-daily capsule, lotiglipron, as a consequence of elevated liver enzymes and a 2 times-day by day pill, danuglipron, as a consequence of robust Unwanted side effects—but CEO Albert Bourla has claimed the company is set to “Participate in and gain” wi… Read More